Needham Remains Positively Inclined Toward FDA CBER Approval for Dendreon (DNDN) Provenge

May 2, 2007 10:24 AM EDT Send to a Friend
Needham issued a note on Dendreon Corp. (Nasdaq: DNDN) with about two week unitl the PDUFA on Provenge. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login